DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call
DaVita Inc. (NYSE: DVA) has announced its upcoming third quarter 2024 investor conference call, scheduled for Tuesday, October 29, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close on the same day. Investors can access the call via webcast or by dialing in, with the password "Earnings" required.
DaVita, a comprehensive kidney care provider, serves approximately 265,100 patients at 3,124 outpatient dialysis centers globally as of June 30, 2024. The company operates 2,672 centers in the United States and 452 centers across 13 other countries. DaVita focuses on transforming care delivery to improve patients' quality of life, offering services from slowing kidney disease progression to supporting transplantation and providing dialysis at home.
DaVita Inc. (NYSE: DVA) ha annunciato la sua prossima conference call per gli investitori relativa al terzo trimestre del 2024, programmata per martedì 29 ottobre 2024, alle 17:00, ora orientale. L'azienda prevede di rilasciare i risultati dopo la chiusura del mercato lo stesso giorno. Gli investitori possono accedere alla chiamata tramite webcast o componendo il numero, con la password "Earnings" richiesta.
DaVita, fornitore completo di cure renal, serve circa 265.100 pazienti in 3.124 centri di dialisi ambulatoriali a livello globale al 30 giugno 2024. L'azienda gestisce 2.672 centri negli Stati Uniti e 452 centri in 13 altri paesi. DaVita si concentra sulla trasformazione della consegna delle cure per migliorare la qualità della vita dei pazienti, offrendo servizi che vanno dal rallentamento della progressione della malattia renale al supporto per il trapianto e alla fornitura di dialisi a domicilio.
DaVita Inc. (NYSE: DVA) ha anunciado su próxima conferencia telefónica con inversores para el tercer trimestre de 2024, programada para el martes 29 de octubre de 2024, a las 5:00 p.m. Hora del Este. La compañía planea publicar sus resultados después del cierre del mercado el mismo día. Los inversores pueden acceder a la llamada a través de un webcast o marcando el número, con la contraseña "Earnings" requerida.
DaVita, proveedor integral de cuidados renales, atiende aproximadamente a 265.100 pacientes en 3.124 centros de diálisis ambulatoria en todo el mundo hasta el 30 de junio de 2024. La empresa opera 2.672 centros en los Estados Unidos y 452 centros en 13 otros países. DaVita se enfoca en transformar la entrega de cuidados para mejorar la calidad de vida de los pacientes, ofreciendo servicios que van desde ralentizar la progresión de la enfermedad renal hasta apoyar el trasplante y proporcionar diálisis a domicilio.
DaVita Inc. (NYSE: DVA)는 2024년 3분기 투자자 컨퍼런스 통화를 2024년 10월 29일 화요일 오후 5시 (동부 시간)으로 예정하고 있다고 발표했습니다. 회사는 당일 증시 마감 후에 결과를 발표할 예정입니다. 투자자는 웹캐스트를 통해 또는 전화를 걸어 "Earnings" 비밀번호로 접근할 수 있습니다.
DaVita는 종합 신장 관리 제공업체로, 2024년 6월 30일 기준으로 전 세계적으로 265,100명의 환자를 3,124개의 외래 투석 센터에서 치료하고 있습니다. 회사는 미국에 2,672개 센터와 13개국에 452개 센터를 운영하고 있습니다. DaVita는 환자의 삶의 질을 향상시키기 위해 치료 서비스의 혁신에 집중하고 있으며, 신장 질환 진행 속도를 늦추는 것부터 이식 지원 및 자택에서의 투석 제공까지 다양한 서비스를 제공합니다.
DaVita Inc. (NYSE: DVA) a annoncé sa prochaine conférence téléphonique pour les investisseurs concernant le troisième trimestre 2024, prévue pour mardi 29 octobre 2024, à 17h00 heure de l'Est. La société prévoit de publier ses résultats après la fermeture des marchés le même jour. Les investisseurs peuvent accéder à l'appel via un webinaire ou en composant le numéro, avec le mot de passe "Earnings" requis.
DaVita, fournisseur complet de soins rénaux, sert environ 265 100 patients dans 3 124 centres de dialyse ambulatoire à l'échelle mondiale au 30 juin 2024. L'entreprise exploite 2 672 centres aux États-Unis et 452 centres dans 13 autres pays. DaVita se concentre sur la transformation de la prestation des soins afin d'améliorer la qualité de vie des patients, offrant des services allant du ralentissement de la progression de la maladie rénale à l'aide au transfert et à la fourniture de dialyse à domicile.
DaVita Inc. (NYSE: DVA) hat seine bevorstehende Investorenkonferenz für das dritte Quartal 2024 angekündigt, die für Dienstag, den 29. Oktober 2024, um 17:00 Uhr Eastern Time geplant ist. Das Unternehmen plant, seine Ergebnisse am selben Tag nach Marktschluss zu veröffentlichen. Investoren können über ein Webcast oder per Telefon teilnehmen, wobei das Passwort "Earnings" erforderlich ist.
DaVita, ein umfassender Anbieter von Nierenpflege, betreut weltweit etwa 265.100 Patienten in 3.124 ambulanten Dialysezentren zum Stand vom 30. Juni 2024. Das Unternehmen betreibt 2.672 Zentren in den Vereinigten Staaten und 452 Zentren in 13 anderen Ländern. DaVita konzentriert sich darauf, die Versorgung zu transformieren, um die Lebensqualität der Patienten zu verbessern, und bietet Dienstleistungen an, die von der Verzögerung des Fortschreitens der Nierenerkrankung bis hin zur Unterstützung von Transplantationen und der Bereitstellung von Dialyse zu Hause reichen.
- None.
- None.
This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:
Tuesday, October 29, 2024
Starting at 5:00 p.m. EDT
Webcast can be accessed using this link
Dial in number: 877-918-6630
International dial in: 517-308-9042
When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of June 30, 2024, DaVita served approximately 265,100 patients at 3,124 outpatient dialysis centers, of which 2,672 centers were located in the United States and 452 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Contact Information
Investors:
IR@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-3rd-quarter-2024-investor-conference-call-302271915.html
SOURCE DaVita
FAQ
When is DaVita's (DVA) Q3 2024 earnings call scheduled?
How can investors access DaVita's (DVA) Q3 2024 conference call?
How many outpatient dialysis centers does DaVita (DVA) operate as of June 30, 2024?
What is the approximate number of patients DaVita (DVA) serves globally?
What types of kidney care services does DaVita (DVA) provide?
